British Society of Blood and Marrow Transplantation and Cellular Therapy
an organisation for those with a professional interest in haematopoietic cell transplantation and cellular therapies
Presence of donor-encoded centromeric KIR B content increases the risk of infectious mortality in recipients of myeloablative, T-cell deplete, HLA-matched HCT to treat AML
© 2023 British Society of Blood and Marrow Transplantation
British Society of Blood and Marrow Transplantation and Cellular Therapies
5th Floor Tabard House, Talbot Yard
Guy's Hospital, Great Maze Pond London.
SE1 9RT United Kingdom
The BSBMTCT is not responsible for the content of external sites
